ACLARION, INC. Preferred Stock Dividends, Income Statement Impact
ACLARION, INC. (ACON) reported Preferred Stock Dividends, Income Statement Impact of $0 for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-07-03.
Discontinued › Operating Expenses
us-gaap:PreferredStockDividendsIncomeStatementImpact · last filed 2023-07-03
- ACLARION, INC. preferred stock dividends, income statement impact for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- ACLARION, INC. preferred stock dividends, income statement impact for the quarter ending 2022-03-31 was $287.31K.
| Period end | Preferred Stock Dividends, Income Statement Impact 3 month |
|---|---|
| 2023-03-31 | $0.00 10-Q · filed 2023-07-03 |
| 2022-03-31 | $287.31K 10-Q · filed 2023-07-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |